Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 9/2015

01-09-2015

Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders

Auteurs: M. Chahua, A. Sánchez-Niubò, M. Torrens, L. Sordo, M. J. Bravo, M. T. Brugal, A. Domingo-Salvany, the ITINERE Project Group

Gepubliceerd in: Quality of Life Research | Uitgave 9/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Drug addiction and psychiatric disorders are frequently concomitant; however, few studies have investigated the impact of psychiatric disorders other than substance use disorder (SUD) on health-related quality of life (HRQoL) in drug users not in treatment. We studied the association of psychiatric disorders other than SUD with HRQoL in a street-recruited sample of cocaine and/or heroin users.

Methods

It is a cross-sectional study involving 287 young users of cocaine and/or heroin in Barcelona, Spain. HRQoL was assessed with the Nottingham health profile (NHP). Patterns of drug use and mental disorders were assessed using the Spanish version of the psychiatric research interview for substance and mental disorders IV, and degree of dependence through the severity of dependence scale (SDS). The association of mental disorders with HRQoL was assessed through a Tobit regression analysis.

Results

The overall NHP score was 23.9 (SD = 20.5, range 0–91.7). Sixty-one percent of the sample had two or more SUDs; 22 % had at least one non-SUD Axis I disorder (anxiety, mood, psychotic, or eating disorder); and 27.2 % had a borderline personality disorder (BPD) and/or antisocial personality disorder. Variables negatively associated with the global NHP score were psychosis [transformed beta coefficient: 15.23; 95 % confidence interval [CI] 4.48–25.97], BPD (9.55; 95 % CI 2.95–16.15), severity of dependence (8.12; 95 % CI 3.37–12.87), having two or more SUDs (for two or three SUDs: 6.83; 95 % CI 2.08–11.59) (>3 SUDs: 7.70; 95 % CI 1.72–13.68) and the intravenous use of some substance (10.20; 95 % CI 6.00–14.40).

Conclusion

HRQoL among street-recruited illegal substance users was impaired, particularly among those with psychiatric comorbidity, psychosis, and BPD being especially relevant.
vorige artikel The relationship between four health-related quality-of-life indicators and use of mammography and Pap test screening in US women
volgende artikel Gender role orientation is associated with health-related quality of life differently among African-American, Hispanic, and White youth
Literatuur
1.
European Monitoring Center for Drugs and Drug Addiction. (2012). The state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities.
2.
Giacomuzzi, S. M., Ertl, M., Kemmler, G., Riemer, Y., & Vigl, A. (2005). Sublingual buprenorphine and methadone maintenance treatment: A three-year follow-up of quality of life assessment. Scientific World Journal, 5, 452–468.PubMedCrossRef
3.
Iraurgi, I., Póo, M., & Márkez, I. (2004). Evaluation of the SF-36 health index applied to methadone maintenance program users. Reference values for the Basque Autonomous Community, Spain. Revista Española de Salud Publica, 78(5), 609–621.CrossRef
4.
Torrens, M., San, L., Martinez, A., Castillo, C., Domingo-Salvany, A., & Alonso, J. (1997). Use of the Nottingham health profile for measuring health status of patients in methadone maintenance treatment. Addiction, 92(6), 707–716.PubMedCrossRef
5.
Millson, P. E., Challacombe, L., Villeneuve, P. J., Fischer, B., Strike, C. J., Myers, T., et al. (2004). Self-perceived health among Canadian opiate users: A comparison to the general population and to other chronic disease populations. Canadian Journal of Public Health, 95(2), 99–103.PubMed
6.
7.
Baum, M. K., Jayaweera, D. T., Duan, R., Sales, S., Lai, S., Rafie, C., et al. (2008). Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami. Journal of Addictive Diseases, 27(2), 37–48.PubMedCrossRef
8.
Falck, R. S., Wang, J., Carlson, R. G., & Siegal, H. A. (2000). Crack-cocaine use and health status as defined by the SF-36. Addictive Behaviors, 25(4), 579–584.PubMedCrossRef
9.
Puigdollers, E., Domingo-Salvany, A., Brugal, M. T., Torrens, M., Alvaros, J., Castillo, C., et al. (2004). Characteristics of heroin addicts entering methadone maintenance treatment: Quality of life and gender. Substance Use and Misuse, 39(9), 1353–1368.PubMedCrossRef
10.
Tiffany, S. T., Friedman, L., Greenfield, S. F., Hasin, D. S., & Jackson, R. (2012). Beyond drug use: A systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction, 107(4), 709–718.PubMedCentralPubMedCrossRef
11.
Comer, J. S., Blanco, C., Hasin, D. S., Liu, S. M., Grant, B. F., Turner, J. B., & Olfson, M. (2011). Health-related quality of life across the anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions (NESARC). The Journal of Clinical Psychiatry, 72(1), 43–50.PubMedCentralPubMedCrossRef
12.
Kessler, R. C., Aguilar-Gaxiola, S., Alonso, J., Chatterji, S., Lee, S., Ormel, J., et al. (2009). The global burden of mental disorders: An update from the WHO world mental health (WMH) surveys. Epidemiologia e Psichiatria Sociale, 18(1), 23–33.PubMedCentralPubMedCrossRef
13.
Perseius, K. I., Andersson, E., Asberg, M., & Samuelsson, M. (2006). Health-related quality of life in women patients with borderline personality disorder. Scandinavian Journal of Caring Sciences, 20(3), 302–307.PubMedCrossRef
14.
Piccinni, A., Catena, M., Del, D. A., Marazziti, D., Monje, C., Schiavi, E., et al. (2007). Health-related quality of life and functioning in remitted bipolar I outpatients. Comprehensive Psychiatry, 48(4), 323–328.PubMedCrossRef
15.
Rubio, J. M., Olfson, M., Villegas, L., Perez-Fuentes, G., Wang, S., & Blanco, C. (2013). Quality of life following remission of mental disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 74(5), e445–e450.PubMedCrossRef
16.
Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566–576.PubMedCrossRef
17.
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., et al. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61(8), 807–816.PubMedCrossRef
18.
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., & Ruan, W. J. (2005). Co-occurrence of DSM-IV personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Comprehensive Psychiatry, 46(1), 1–5.PubMedCrossRef
19.
Hasin, D., Fenton, M. C., Skodol, A., Krueger, R., Keyes, K., Geier, T., et al. (2011). Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders. Archives of General Psychiatry, 68(11), 1158–1167.PubMedCentralPubMedCrossRef
20.
Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64(7), 830–842.PubMedCrossRef
21.
Aharonovich, E., Liu, X., Nunes, E., & Hasin, D. S. (2002). Suicide attempts in substance abusers: Effects of major depression in relation to substance use disorders. The American Journal of Psychiatry, 159(9), 1600–1602.PubMedCrossRef
22.
Burns, L., Teesson, M., & O’Neill, K. (2005). The impact of comorbid anxiety and depression on alcohol treatment outcomes. Addiction, 100(6), 787–796.PubMedCrossRef
23.
King, V. L., Kidorf, M. S., Stoller, K. B., & Brooner, R. K. (2000). Influence of psychiatric comorbidity on HIV risk behaviors: Changes during drug abuse treatment. Journal of Addictive Diseases, 19(4), 65–83.PubMedCrossRef
24.
Curran, G. M., Sullivan, G., Williams, K., Han, X., Collins, K., Keys, J., & Kotrla, K. J. (2003). Emergency department use of persons with comorbid psychiatric and substance abuse disorders. Annals of Emergency Medicine, 41(5), 659–667.PubMedCrossRef
25.
Lejoyeux, M., Boulenguiez, S., Fichelle, A., McLoughlin, M., Claudon, M., & Ades, J. (2000). Alcohol dependence among patients admitted to psychiatric emergency services. General Hospital Psychiatry, 22(3), 206–212.PubMedCrossRef
26.
Martín-Santos, R., Fonseca, F., Domingo-Salvany, A., Ginés, J. M., Ímaz, M. L., Navinés, R., et al. (2006). Dual diagnosis in the psychiatric emergency room in Spain. The European Journal of Psychiatry, 20, 147–156.CrossRef
27.
Astals, M., Domingo-Salvany, A., Buenaventura, C. C., Tato, J., Vázquez, J. M., Martín-Santos, R., & Torrens, M. (2008). Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Substance Use and Misuse, 43(5), 612–632.PubMedCrossRef
28.
Bizzarri, J., Rucci, P., Vallotta, A., Girelli, M., Scandolari, A., Zerbetto, E., et al. (2005). Dual diagnosis and quality of life in patients in treatment for opioid dependence. Substance Use and Misuse, 40(12), 1765–1776.PubMedCrossRef
29.
Carpentier, P. J., Krabbe, P. F., van Gogh, M. T., Knapen, L. J., Buitelaar, J. K., & de Jong, C. A. (2009). Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. American Journal on Addictions, 18(6), 470–480.PubMedCrossRef
30.
Domingo-Salvany, A., Brugal, M. T., Barrio, G., Gonzalez-Saiz, F., Bravo, M. J., & de la Fuente, L. (2010). Gender differences in health related quality of life of young heroin users. Health and Quality of Life Outcomes, 8, 145.PubMedCentralPubMedCrossRef
31.
Lozano, O. M., Domingo-Salvany, A., Martinez-Alonso, M., Brugal, M. T., Alonso, J., & de la Fuente, L. (2008). Health-related quality of life in young cocaine users and associated factors. Quality of Life Research, 17(7), 977–985.PubMedCrossRef
32.
Herrero, M. J., Domingo-Salvany, A., Torrens, M., & Brugal, M. T. (2008). Psychiatric comorbidity in young cocaine users: Induced versus independent disorders. Addiction, 103(2), 284–293.PubMedCrossRef
33.
Rodríguez-Llera, M. C., Domingo-Salvany, A., Brugal, M. T., Silva, T. C., Sánchez-Niubó, A., & Torrens, M. (2006). Psychiatric comorbidity in young heroin users. Drug and Alcohol Dependence, 84(1), 48–55.PubMedCrossRef
34.
de la Fuente, L., Brugal, M. T., Ballesta, R., Bravo, M. J., Barrio, G., Domingo-Salvany, A., et al. (2005). Cohort study methodology of the ITINERE project on heroin users in three Spanish cities and main characteristics of the participants. Revista Española de Salud Publica, 79(4), 475–491.
35.
Pulido, J., Brugal, M. T., de la Fuente, L., Ballesta, R., Barrio, G., Bravo, M. J., et al. (2009). Recruitment methodology and characteristics of a cohort of young regular cocaine users in three Spanish cities (the itinere-cocaine project). Gaceta Sanitaria, 23(3), 200–207.PubMedCrossRef
36.
37.
Alonso, J., Anto, J. M., & Moreno, C. (1990). Spanish version of the Nottingham health profile: Translation and preliminary validity. American Journal of Public Health, 80(6), 704–708.PubMedCentralPubMedCrossRef
38.
Torrens, M., Serrano, D., Astals, M., Pérez-Domínguez, G., & Martín-Santos, R. (2004). Diagnosing comorbid psychiatric disorders in substance abusers: Validity of the Spanish versions of the psychiatric research interview for substance and mental disorders and the structured clinical interview for DSM-IV. The American Journal of Psychiatry, 161(7), 1231–1237.PubMedCrossRef
39.
Hasin, D., Samet, S., Nunes, E., Meydan, J., Matseoane, K., & Waxman, R. (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the psychiatric research interview for substance and mental disorders for DSM-IV. The American Journal of Psychiatry, 163(4), 689–696.PubMedCrossRef
40.
González-Sáiz, F., De las Cuevas, C., Barrio, G., & Domingo-Salvany, A. (2008). Versión española consensuada de la severity of dependence scale (SDS). Medicina Clinica, 131(20), 797.PubMedCrossRef
41.
Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995). The severity of dependence scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90(5), 607–614.PubMedCrossRef
42.
Tobin, J. (1958). Estimation of relationships for limited dependent variables. Econometrica, 26(1), 24–36.
43.
Bleda, M. J., & Tobias, A. (2002). Application of tobit regression models in modelling censored epidemiological variables. Gaceta Sanitaria, 16(2), 188–195.CrossRef
44.
Greene, W. (1997). Econometric analysis (3rd ed.). Saddle River, New Jersey: Prentice Hall.
45.
SPSS Inc. & IBM Company. (2010). Statistical program for the social sciences. SPSS.
46.
Core Team, R. (2012). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
47.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
48.
González-Sáiz, F., Domingo-Salvany, A., Barrio, G., Sánchez-Niubò, A., Brugal, M. T., de la Fuente, L., & Alonso, J. (2009). Severity of dependence scale as a diagnostic tool for heroin and cocaine dependence. European Addiction Research, 15(2), 87–93.PubMedCrossRef
49.
Alonso, J., Prieto, L., & Anto, J. M. (1994). The Spanish version of the Nottingham health profile: A review of adaptation and instrument characteristics. Quality of Life Research, 3(6), 385–393.PubMedCrossRef
50.
Ware, J. E., Kosinski, M., Turner-Bowker, D. M., & Gandek, B. (2002). How to score version 2 of the SF-12 health survey. Lincoln, RI: Quality Metrics.
51.
Swartz, M. S., Wagner, H. R., Swanson, J. W., Stroup, T. S., McEvoy, J. P., Canive, J. M., et al. (2006). Substance use in persons with schizophrenia: Baseline prevalence and correlates from the NIMH CATIE study. The Journal of Nervous and Mental Disease, 194(3), 164–172.PubMedCrossRef
52.
Owen, R. R., Fischer, E. P., Booth, B. M., & Cuffel, B. J. (1996). Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services, 47(8), 853–858.PubMedCrossRef
53.
Linszen, D. H., Dingemans, P. M., & Lenior, M. E. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry, 51(4), 273–279.PubMedCrossRef
54.
Eack, S. M., & Newhill, C. E. (2007). Psychiatric symptoms and quality of life in schizophrenia: A meta-analysis. Schizophrenia Bulletin, 33(5), 1225–1237.PubMedCentralPubMedCrossRef
55.
Gibbie, T. M., Hides, L. M., Cotton, S. M., Lubman, D. I., Aitken, C., & Hellard, M. (2011). The relationship between personality disorders and mental health, substance use severity and quality of life among injecting drug users. The Medical Journal of Australia, 195(3), S16–S21.PubMed
56.
Soeteman, D. I., Hakkaart-van, R. L., Verheul, R., & Busschbach, J. J. (2008). The economic burden of personality disorders in mental health care. The Journal of Clinical Psychiatry, 69(2), 259–265.PubMedCrossRef
57.
Jackson, H. J., & Burgess, P. M. (2000). Personality disorders in the community: A report from the Australian National Survey of Mental Health and Wellbeing. Social Psychiatry and Psychiatric Epidemiology, 35(12), 531–538.PubMedCrossRef
58.
Masthoff, E. D., Trompenaars, F. J., van Heck, G. L., Michielsen, H. J., Hodiamont, P. P., & De Vries, J. (2007). Predictors of quality of life: A model based study. Quality of Life Research, 16(2), 309–320.PubMedCrossRef
59.
Del Boca, F. K., & Darkes, J. (2003). The validity of self-reports of alcohol consumption: State of the science and challenges for research. Addiction, 98(Suppl. 2), 1–12.PubMedCrossRef
Metagegevens
Titel
Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders
Auteurs
M. Chahua
A. Sánchez-Niubò
M. Torrens
L. Sordo
M. J. Bravo
M. T. Brugal
A. Domingo-Salvany
the ITINERE Project Group
Publicatiedatum
01-09-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 9/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-0943-5

Andere artikelen Uitgave 9/2015

Quality of Life Research 9/2015 Naar de uitgave

OriginalPaper

Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population

OriginalPaper

Consistency of prediction across generation: explaining quality of life by family functioning and health-promoting behaviors

OriginalPaper

Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate’s egg

Erratum

Erratum to: A new computerized adaptive test advancing the measurement of health-related quality of life (HRQoL) in children: the Kids-CAT

Brief Communication

A longitudinal analysis on pain treatment satisfaction among Chinese patients with chronic pain: predictors and association with medical adherence, disability, and quality of life

Brief Communication

An audit of diabetes-dependent quality of life in patients with type 2 diabetes mellitus in Malaysia